Get the Stockscreener App
177.91
2.79%
5.0076
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $177.91, with a volume of 461.46K.
It is up +2.79% in the last 24 hours and up +9.39% over the past month.
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$172.90
Open:
$173.64
24h Volume:
461.46K
Relative Volume:
0.52
Market Cap:
$19.44B
Revenue:
$9.54B
Net Income/Loss:
$841.00M
P/E Ratio:
23.91
EPS:
7.44
Net Cash Flow:
$1.02B
1W Performance:
+2.10%
1M Performance:
+9.39%
6M Performance:
+13.22%
1Y Performance:
+42.54%
1-Day Range:
$173.25
$177.99
1-Week Range:
$171.00
$177.84
52-Week Range:
$123.88
$177.84
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
177.91 | 19.44B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
525.32 | 198.19B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.44 | 148.92B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
128.02 | 36.52B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
440.16 | 35.63B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
188.22 | 33.12B | 15.41B | 1.37B | 2.11B | 7.50 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics Stock Hits All-Time High at $176.53 By Investing.com - Investing.com Canada
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge? - Nasdaq
Pine Valley Investments Ltd Liability Co Decreases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
SVB Wealth LLC Acquires Shares of 68,575 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
National Pension Service Sells 9,262 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Versor Investments LP Has $664,000 Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics EVP Catherine Doherty sells $142,230 in stock By Investing.com - Investing.com Canada
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Bank of New York Mellon Corp - MarketBeat
Quest Diagnostics (NYSE:DGX) Reaches New 52-Week HighStill a Buy? - MarketBeat
Quest Diagnostics SVP sells $91,138 in stock By Investing.com - Investing.com South Africa
Quest Diagnostics EVP Catherine Doherty sells $142,230 in stock - Investing.com
Quest Diagnostics SVP sells $91,138 in stock - Investing.com India
IFP Advisors Inc Has $2.35 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
QRG Capital Management Inc. Purchases 2,012 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
SEC Form 144 filed by Quest Diagnostics Incorporated - Quantisnow
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.80 - Yahoo Finance
New Jersey Court Applies CIPA’s Party Exception to Pixel Wiretap Complaint - Inside Privacy
New York State Common Retirement Fund Sells 6,987 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest to buy Fresenius Medical Care kidney testing assets - MedTech Dive
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now? - MSN
Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Sanctuary Advisors LLC - MarketBeat
Are Wall Street Analysts Bullish on Quest Diagnostics Stock? - Nasdaq
Fresenius Medical Care Divests Laboratory Assets to Quest Diagnostics - TipRanks
FMC AG Divests Select Laboratory Assets To Quest Diagnostics -February 24, 2025 at 08:03 am EST - Marketscreener.com
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - PR Newswire
Quest Diagnostics to Acquire Select Laboratory Assets of Fresenius Medical Care Unit - Marketscreener.com
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - MSN
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus.com
Quest Diagnostics SVP Michael Prevoznik sells $103,277 in stock By Investing.com - Investing.com Australia
Quest Diagnostics SVP Plewman sells $54,307 in stock By Investing.com - Investing.com Australia
Quest Diagnostics SVP Plewman sells $54,307 in stock - Investing.com
Quest Diagnostics SVP Michael Prevoznik sells $103,277 in stock - Investing.com
New York State Teachers Retirement System Cuts Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Hits New 52-Week HighTime to Buy? - MarketBeat
Principal Financial Group Inc. Acquires 104,495 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Van ECK Associates Corp - MarketBeat
Vontobel Holding Ltd. Has $7.14 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Chevy Chase Trust Holdings LLC Has $15.36 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.
Quest Diagnostics stock hits 52-week high at $171.42 By Investing.com - Investing.com Nigeria
Quest Diagnostics stock hits 52-week high at $171.42 - Investing.com
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Is There An Opportunity With Quest Diagnostics Incorporated's (NYSE:DGX) 50% Undervaluation? - Yahoo Finance UK
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Rhumbline Advisers Sells 8,647 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Empowered Funds LLC - MarketBeat
Savant Capital LLC Raises Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
MOKAN Wealth Management Inc. Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Sheaff Brock Investment Advisors LLC Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.79%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):